share_log

Beyond The Numbers: 4 Analysts Discuss National Health Investors Stock

Beyond The Numbers: 4 Analysts Discuss National Health Investors Stock

超越数字:4位分析师讨论国民健康投资者股票
Benzinga ·  03/12 08:00
National Health Investors (NYSE:NHI) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
国民健康投资者(纽约证券交易所代码:NHI)在上个季度接受了4位分析师的分析,揭示了从看涨到看跌的一系列观点。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
下表汇总了他们最近的评级,阐明了过去30天内情绪的变化,并将其与前几个月进行了比较。
In the assessment of 12-month price targets, analysts unveil insights for National Health Investors, presenting an average target of $65.75, a high estimate of $69.00, and a low estimate of $63.00. This upward trend is evident, with the current average reflecting a 17.41% increase from the previous average price target of $56.00.
在评估12个月目标股价时,分析师公布了对国家健康投资者的见解,将平均目标价定为65.75美元,最高估计为69.00美元,低估值为63.00美元。这种上升趋势显而易见,当前的平均价格较之前的平均目标价56.00美元上涨了17.41%。
Decoding Analyst Ratings: A Detailed Look
解码分析师评级:详细介绍
The...
对...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发